HIV and schistosomiasis co-infection in African children

The Lancet Infectious Diseases

Volumn 14, Issue 7, 2014, Pages 640-649

  Bustinduy, Amaya ^a   King, Charles ^b   Scott, Janet ^c   Appleton, Sarah ^d   Sousa Figueiredo, José Carlos ^a   Betson, Martha ^e   Stothard, J Russell ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; CHILD; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFLAMMATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SCHISTOSOMIASIS; TREATMENT OUTCOME; VIRUS IDENTIFICATION; VIRUS TRANSMISSION;

AFRICA; CHILD; COINFECTION; HIV INFECTIONS; HUMANS; RISK FACTORS; SCHISTOSOMIASIS;

EID: 84904767992     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70001-5     Document Type: Review

References (119)

1. Hotez PJ, Kamath A Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009, 3:e412.
2. Gryseels B, Polman K, Clerinx J, Kestens L Human schistosomiasis. Lancet 2006, 368:1106-1118.
3. Global report: UNAIDS report on the global AIDS epidemic 2010 2010, UNAIDS, United Nations Programme on HIV/AIDS, Geneva.
4. Boender TS, Sigaloff KC, Kayiwa J, et al. Barriers to initiation of pediatric HIV treatment in Uganda: a mixed-method study. AIDS Res Treat 2012, 2012:817506.
5. WHO recommendations on the diagnosis of HIV infection in infants and children 2010, WHO, World Health Organization, Geneva.
6. Dept of HIV/AIDS. Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach 2007, WHO, World Health Organization, Geneva.
7. Progress report on the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive 2011, UNAIDS, United Nations Programme on HIV/AIDS, Geneva.
8. Garba A, Barkiré N, Djibo A, et al. Schistosomiasis in infants and preschool-aged children: infection in a single Schistosoma haematobium and a mixed S haematobium-S mansoni foci of Niger. Acta Trop 2010, 115:212-219.
9. Sousa-Figueiredo JC, Pleasant J, Day M, et al. Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole. Int Health 2010, 2:103-113.
10. Crompton DWT Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers 2006, WHO, World Health Organization, Geneva.
11. Fenwick A, Webster JP, Bosque-Oliva E, et al. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 2009, 136:1719-1730.
12. Stothard JR, Sousa-Figueiredo JC, Betson M, et al. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. Parasitology 2011, 138:1593-1606.
13. Report of a meeting to review the results of studies on the treatment of schistosomiasis in preschool-aged children 2011, WHO, World Health Organization, Geneva.
14. Fairley J Bilharzia. A history of imperial tropical medicine 1991, Cambridge University Press, Cambridge.
15. King CH Parasites and poverty: the case of schistosomiasis. Acta Trop 2010, 113:95-104.
16. Coates TJ, Richter L, Caceres C Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet 2008, 372:669-684.
17. Bruun B, Aagaard-Hansen J The social context of schistosomiasis and its control: an introduction and annotated bibliography 2008, for the UNICEF, UNDP, World Bank, WHO Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva.
18. Utzinger J A research and development agenda for the control and elimination of human helminthiases. PLoS Negl Trop Dis 2012, 6:e1646.
19. Malaria and HIV/AIDS interactions and implications: conclusions of a technical consultation convened by WHO, 23-25 June 2004 2004, WHO, World Health Organization, Geneva.
20. Pneumocystis pneumonia-Los Angeles. MMWR Morb Mortal Wkly Rep 1981, 30:250-252. CDC.
21. Quinn TC, Mann JM, Curran JW, Piot P AIDS in Africa: an epidemiologic paradigm. Science 1986, 234:955-963.
22. Odogwu SE, Ramamurthy NK, Kabatereine NB, et al. Schistosoma mansoni in infants (aged <3 years) along the Ugandan shoreline of Lake Victoria. Ann Trop Med Parasitol 2006, 100:315-326.
23. Sousa-Figueiredo JC, Basáñez MG, Mgeni AF, Khamis IS, Rollinson D, Stothard JR A parasitological survey, in rural Zanzibar, of pre-school children and their mothers for urinary schistosomiasis, soil-transmitted helminthiases and malaria, with observations on the prevalence of anaemia. Ann Trop Med Parasitol 2008, 102:679-692.
24. Verani JR, Abudho B, Montgomery SP, et al. Schistosomiasis among young children in Usoma, Kenya. Am J Trop Med Hyg 2011, 84:787-791.
25. Bustinduy AL, Thomas CL, Fiutem JJ, et al. Measuring fitness of Kenyan children with polyparasitic infections using the 20-meter shuttle run test as a morbidity metric. PLoS Negl Trop Dis 2011, 5:e1213.
26. Ezeamama AE, Friedman JF, Acosta LP, et al. Helminth infection and cognitive impairment among Filipino children. Am J Trop Med Hyg 2005, 72:540-548.
27. Stephenson LS, Latham MC, Adams EJ, Kinoti SN, Pertet A Physical fitness, growth and appetite of Kenyan school boys with hookworm, Trichuris trichiura and Ascaris lumbricoides infections are improved four months after a single dose of albendazole. J Nutr 1993, 123:1036-1046.
28. King CH, Dangerfield-Cha M The unacknowledged impact of chronic schistosomiasis. Chronic Illn 2008, 4:65-79.
29. King CH, Dickman K, Tisch DJ Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005, 365:1561-1569.
30. Webb EL, Ekii AO, Pala P Epidemiology and immunology of helminth-HIV interactions. Curr Opin HIV AIDS 2012, 7:245-253.
31. Secor WE, Sundstrom JB Below the belt: new insights into potential complications of HIV-1/schistosome coinfections. Curr Opin Infect Dis 2007, 20:519-523.
32. Stothard JR, Chiodini P, Booth M Progress in paediatric parasitology: a preface to a topic focusing on ever younger subjects. Parasitology 2011, 138:1453-1458.
33. Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis 2002, 6:1038-1045.
34. Karanja DM, Colley DG, Nahlen BL, Ouma JH, Secor WE Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg 1997, 56:515-521.
35. Fontanet AL, Woldemichael T, Sahlu T, et al. Epidemiology of HIV and Schistosoma mansoni infections among sugar-estate residents in Ethiopia. Ann Trop Med Parasitol 2000, 94:145-155.
36. N'Zoukoudi-N'Doundou MY, Dirat I, Akouala JJ, Penchenier L, Makuwa M, Rey JL Bilharziasis and human immunodeficiency virus infection in Congo. Med Trop (Mars) 1995, 55:249-251.
37. Kallestrup P, Zinyama R, Gomo E, et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs. J Infect Dis 2005, 191:1311-1320.
38. Sabah AA, Fletcher C, Webbe G, Doenhoff MJ Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice. Exp Parasitol 1985, 60:348-354.
39. Ayash-Rashkovsky M, Chenine AL, Steele LN, et al. Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection. Infect Immun 2007, 75:1751-1756.
40. Hosseinipour MC, Napravnik S, Joaki G, et al. HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi. J Infect Dis 2007, 195:1278-1282.
41. Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, et al. Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis. Am J Trop Med Hyg 2008, 79:331-337.
42. Brown M, Mawa PA, Joseph S, et al. Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults. J Infect Dis 2005, 191:1648-1657.
43. Kallestrup P, Zinyama R, Gomo E, et al. Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection. Clin Infect Dis 2006, 42:1781-1789.
44. Bangirana P, Musisi S, Boivin MJ, et al. Malaria with neurological involvement in Ugandan children: effect on cognitive ability, academic achievement and behaviour. Malar J 2011, 10:334.
45. Smith R, Malee K, Leighty R, et al. Effects of perinatal HIV infection and associated risk factors on cognitive development among young children. Pediatrics 2006, 117:851-862. for the Women and Infants Transmission Study Group.
46. De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000, 283:1175-1182.
47. Gallagher M, Malhotra I, Mungai PL, et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS 2005, 19:1849-1855.
48. Webb EL, Kyosiimire-Lugemwa J, Kizito D, et al. The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double-blind, placebo-controlled trial in Uganda. J Acquir Immune Defic Syndr 2012, 60:307-313.
49. Bearer CF How are children different from adults?. Environ Health Perspect 1995, 103:7-12.
50. Arpadi SM, Cuff PA, Kotler DP, et al. Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV-infected children. J Nutr 2000, 130:2498-2502.
51. Friedman JF, Kanzaria HK, Acosta LP, et al. Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines. Am J Trop Med Hyg 2005, 72:527-533.
52. Routledge PA Pharmacokinetics in children. J Antimicrob Chemother 1994, 34(suppl):19-24.
53. Doenhoff MJ, Cioli D, Utzinger J Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008, 21:659-667.
54. Secor WE Interactions between schistosomiasis and infection with HIV-1. Parasite Immunol 2006, 28:597-603.
55. Black CL, Mwinzi PN, Muok EM, et al. Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni. PLoS Negl Trop Dis 2010, 4:e637.
56. Mott KE, Dixon H, Osei-Tutu E, England EC Relation between intensity of Schistosoma haematobium infection and clinical haematuria and proteinuria. Lancet 1983, 1:1005-1008.
57. Jamison DT, Mosley WH Disease control priorities in developing countries: health policy responses to epidemiological change. Am J Public Health 1991, 81:15-22.
58. King CH, Bertino AM Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis 2008, 2:e209.
59. Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa. PLoS One 2011, 6:e22706.
60. Sutcliffe CG, van Dijk JH, Munsanje B, et al. Risk factors for pre-treatment mortality among HIV-infected children in rural Zambia: a cohort study. PLoS One 2011, 6:e29294.
61. Friedman JF, Kanzaria HK, McGarvey ST Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol 2005, 21:386-392.
62. Stephenson LS, Latham MC, Kurz KM, Kinoti SN, Oduori ML, Crompton DW Relationships of Schistosoma hematobium, hookworm and malarial infections and metrifonate treatment to hemoglobin level in Kenyan school children. Am J Trop Med Hyg 1985, 34:519-528.
63. Mupfasoni D, Karibushi B, Koukounari A, et al. Polyparasite helminth infections and their association to anaemia and undernutrition in Northern Rwanda. PLoS Negl Trop Dis 2009, 3:e517.
64. Koukounari A, Estambale BB, Njagi JK, et al. Relationships between anaemia and parasitic infections in Kenyan schoolchildren: a Bayesian hierarchical modelling approach. Int J Parasitol 2008, 38:1663-1671.
65. Simoonga C, Kazembe LN, Kristensen TK, et al. The epidemiology and small-scale spatial heterogeneity of urinary schistosomiasis in Lusaka province, Zambia. Geospat Health 2008, 3:57-67.
66. Saathoff E, Olsen A, Magnussen P, Kvalsvig JD, Becker W, Appleton CC Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa. BMC Infect Dis 2004, 4:40.
67. King CH Long-term outcomes of school-based treatment for control of urinary schistosomiasis: a review of experience in Coast Province, Kenya. Mem Inst Oswaldo Cruz 2006, 101(suppl):299-306.
68. Secor WE, Karanja DM, Colley DG Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya. Mem Inst Oswaldo Cruz 2004, 99(suppl):93-95.
69. Mwinzi PN, Karanja DM, Kareko I, et al. Short report: evaluation of hepatic fibrosis in persons co-infected with Schistosoma mansoni and human immunodeficiency virus 1. Am J Trop Med Hyg 2004, 71:783-786.
70. Jourdan PM, Holmen SD, Gundersen SG, Roald B, Kjetland EF HIV target cells in Schistosoma haematobium-infected female genital mucosa. Am J Trop Med Hyg 2011, 85:1060-1064.
71. Jourdan PM, Roald B, Poggensee G, Gundersen SG, Kjetland EF Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection. PLoS Negl Trop Dis 2011, 5:e1170.
72. Mwinzi PN, Karanja DM, Colley DG, Orago AS, Secor WE Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection. J Infect Dis 2001, 184:488-496.
73. McElroy MD, Elrefaei M, Jones N, et al. Coinfection with Schistosoma mansoni is associated with decreased HIV-specific cytolysis and increased IL-10 production. J Immunol 2005, 174:5119-5123.
74. Downs JA, Mguta C, Kaatano GM, et al. Urogenital schistosomiasis in women of reproductive age in Tanzania's Lake Victoria region. Am J Trop Med Hyg 2011, 84:364-369.
75. Kjetland EF, Ndhlovu PD, Gomo E, et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 2006, 20:593-600.
76. Ndhlovu PD, Mduluza T, Kjetland EF, et al. Prevalence of urinary schistosomiasis and HIV in females living in a rural community of Zimbabwe: does age matter?. Trans R Soc Trop Med Hyg 2007, 101:433-438.
77. Leutscher P, Ramarokoto CE, Reimert C, Feldmeier H, Esterre P, Vennervald BJ Community-based study of genital schistosomiasis in men from Madagascar. Lancet 2000, 355:117-118.
78. Leutscher PD, Pedersen M, Raharisolo C, et al. Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals. J Infect Dis 2005, 191:1639-1647.
79. Chenine AL, Shai-Kobiler E, Steele LN, et al. Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure. PLoS Negl Trop Dis 2008, 2:e265.
80. Dietze KK, Zelinskyy G, Gibbert K, et al. Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points. Proc Natl Acad Sci USA 2011, 108:2420-2425.
81. Pesce JT, Ramalingam TR, Mentink-Kane MM, et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 2009, 5:e1000371.
82. Cloke TE, Garvey L, Choi BS, et al. Increased level of arginase activity correlates with disease severity in HIV-seropositive patients. J Infect Dis 2010, 202:374-385.
83. Secor WE, Shah A, Mwinzi PM, Ndenga BA, Watta CO, Karanja DM Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4(+) T cells and monocytes of patients with Schistosoma mansoni infection. Infect Immun 2003, 71:6668-6671.
84. Brindley PJ, Sher A The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J Immunol 1987, 139:215-220.
85. Karanja DM, Boyer AE, Strand M, et al. Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg 1998, 59:307-311.
86. Mwanakasale V, Vounatsou P, Sukwa TY, Ziba M, Ernest A, Tanner M Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. Am J Trop Med Hyg 2003, 69:420-428.
87. Walson JL, Herrin BR, John-Stewart G Deworming helminth co-infected individuals for delaying HIV disease progression. Cochrane Database Syst Rev 2009, 3. CD006419.
88. Sangaré LR, Herrin BR, John-Stewart G, Walson JL Species-specific treatment effects of helminth/HIV-1 co-infection: a systematic review and meta-analysis. Parasitology 2011, 138:1546-1558.
89. Kallestrup P, Zinyama R, Gomo E, et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis 2005, 192:1956-1961.
90. Wolday D, Mayaan S, Mariam ZG, et al. Treatment of intestinal worms is associated with decreased HIV plasma viral load. J Acquir Immune Defic Syndr 2002, 31:56-62.
91. Elliott AM, Mawa PA, Joseph S, et al. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Trans R Soc Trop Med Hyg 2003, 97:103-108.
92. Lawn SD, Karanja DM, Mwinzia P, et al. The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS 2000, 14:2437-2443.
93. Modjarrad K, Zulu I, Redden DT, et al. Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J Infect Dis 2005, 192:1277-1283.
94. Mutapi F, Rujeni N, Bourke C, et al. Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl Trop Dis 2011, 5:e1143.
95. Sousa-Figueiredo JC, Betson M, Atuhaire A, et al. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl Trop Dis 2012, 6:e1864.
96. Fox EBF, Balis FM Drug Therapy in Neonates and Pediatric Patients. Principles of Clinical Pharmacology 2007, 359-373. Elsevier, Amsterdam. 2nd edn. A.J. Atkinson, D.R. Abernethy, C.E. Daniels, R.L. Dedrick, S.P. Markey (Eds.).
97. Shimada T, Yamazaki H, Mimura M, et al. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab Dispos 1996, 24:515-522.
98. Hines RN, McCarver DG The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 2002, 300:355-360.
99. Coutinho HM, Acosta LP, McGarvey ST, et al. Nutritional status improves after treatment of Schistosoma japonicum-infected children and adolescents. J Nutr 2006, 136:183-188.
100. Gonzalez FJ Overview of experimental approaches for study of drug metabolism and drug-drug interactions. Drug-drug interactions: scientific and regulatory perspectives 1997, 255-269. Academic Press, Waltham. A.P. Li (Ed.).
101. Patzschke K, Pütter J, Wegner LA, Horster FA, Diekmann HW Serum concentrations and renal excretion in humans after oral administration of praziquantel-results of three determination methods. Eur J Drug Metab Pharmacokinet 1979, 4:149-156.
102. Li XQ, Björkman A, Andersson TB, Gustafsson LL, Masimirembwa CM Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol 2003, 59:429-442.
103. Ridtitid W, Wongnawa M, Mahatthanatrakul W, Punyo J, Sunbhanich M Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers. Clin Pharmacol Ther 2002, 72:505-513.
104. Dooley KE, Flexner C, Andrade AS Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries. J Infect Dis 2008, 198:948-961.
105. Bapiro TE, Egnell AC, Hasler JA, Masimirembwa CM Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos 2001, 29:30-35.
106. Bapiro TE, Sayi J, Hasler JA, et al. Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans. Eur J Clin Pharmacol 2005, 61:755-761.
107. Sweetman SC Martindale: The Complete Drug Reference 2012, Pharmaceutical Press, London. 37th edn.
108. Nishimura Y, Kurata N, Sakurai E, Yasuhara H Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities. J Pharmacol Sci 2004, 96:293-300.
109. Clarithromycin S 2012, Sandoz, Sandoz, Camberley.
110. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000, 1:107-115.
111. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003, 349:1341-1348. for the Vaccine Trialists Group.
112. Bertolini DV, Costa LS, van der Heijden IM, Sato HK, Marques HH Immunogenicity of a meningococcal serogroup C conjugate vaccine in HIV-infected children, adolescents, and young adults. Vaccine 2012, 30:5482-5486.
113. Scott P, Moss WJ, Gilani Z, Low N Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis 2011, 204(suppl):S164-S178.
114. Sutcliffe CG, Moss WJ Do children infected with HIV receiving HAART need to be revaccinated?. Lancet Infect Dis 2010, 10:630-642.
115. Labeaud AD, Malhotra I, King MJ, King CL, King CH Do antenatal parasite infections devalue childhood vaccination?. PLoS Negl Trop Dis 2009, 3:e442.
116. Malhotra I, Mungai P, Wamachi A, et al. Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999, 162:6843-6848.
117. Webb EL, Mawa PA, Ndibazza J, et al. Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial. Lancet 2011, 377:52-62.
118. Brown M, Kizza M, Watera C, et al. Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J Infect Dis 2004, 190:1869-1879.
119. Kurtis JD, Friedman JF, Leenstra T, et al. Pubertal development predicts resistance to infection and reinfection with Schistosoma japonicum. Clin Infect Dis 2006, 42:1692-1698.